IiSGM presents the world's first non-invasive real-time global heart mapping system

A spin-off of the Gregorio Marañón Institute for Health Research has created the world's first non-invasive system for real-time global mapping of the heart. This applied technology was presented in a demonstration held at the hospital's Materno-Infantil facility. It is a technological innovation consisting of a vest with electrodes which, attached to the torso of the person being studied, make it possible to record the electrical activity in all the chambers of the main organ of the circulatory system simultaneously, quickly (in just 10 minutes) and accurately.

With this device, doctors can observe a three-dimensional representation, without having to subject the patient to catheterisation, a computerised axial tomography (CT) scan or a prior MRI scan, thereby improving their safety and comfort, as well as the detection and treatment of arrhythmias, facilitating clinical decision-making in an optimal timeframe.

Another advantage is for the hospital itself, which can significantly reduce the costs associated with the management of arrhythmias, as Cardiology is one of the departments that includes the most resources and patients. Corify is the result of 20 years of work by the team from the Cardiology Department of the Marañón Translational Research Laboratory, with the collaboration of its Institute for Health Research and Innovation Support Unit. They worked together with professionals from the Polytechnic University of Valencia.

Facilitates diagnosis and surgery 

Corify facilitates both diagnosis before deciding whether an intervention is necessary and support during catheterisations, helping clinicians identify the region of the heart that causes irregularity and imbalance in its functioning. This cutting-edge technology has obtained CE certification, allowing it to be sold commercially in the European Union and used in hospitals and cardiac care centres across the old continent.

Arrhythmias, such as atrial fibrillation and ventricular tachycardia, affect millions of people worldwide, posing significant health risks. More than 30% of adults will suffer from some form of this condition, increasing the risk of mortality and also of suffering a stroke or heart failure, a problem that is also on the rise. Traditional methods for studying the electrical activity of the main organ of the circulatory system are less effective, more incomplete, or need to be combined with complex radiological systems that are more harmful to the patient.

Corify, which was chosen as the innovation of the year by the European Institute of Innovation and Technology of the European Commission in 2020, has helped to strengthen the Gregorio Marañón's leadership in the field of cardiovascular health.